Statement: There is the same number of cases of Diplopia in the primary trial as anemia in the secondary trial.
Primary_evidence: Adverse Events 1:   Total: 1/6 (16.67%)   Angina pectoris 0/6 (0.00%)   Pericardial effusion 0/6 (0.00%)   Diplopia 0/6 (0.00%)   Abdominal pain 0/6 (0.00%)   Colitis 0/6 (0.00%)   Gastritis 0/6 (0.00%)   Nausea 0/6 (0.00%)   Vomiting 0/6 (0.00%)   Fatigue 0/6 (0.00%)   General physical health deterioration 0/6 (0.00%)   Generalised oedema 0/6 (0.00%)   Hepatic failure  [1]0/6 (0.00%) Adverse Events 2:   Total: 2/6 (33.33%)   Angina pectoris 0/6 (0.00%)   Pericardial effusion 0/6 (0.00%)   Diplopia 0/6 (0.00%)   Abdominal pain 0/6 (0.00%)   Colitis 0/6 (0.00%)   Gastritis 0/6 (0.00%)   Nausea 0/6 (0.00%)   Vomiting 0/6 (0.00%)   Fatigue 0/6 (0.00%)   General physical health deterioration 0/6 (0.00%)   Generalised oedema 0/6 (0.00%)   Hepatic failure  [1]0/6 (0.00%)
Secondary_evidence: Adverse Events 1:   Total: 0/2 (0.00%)   ANAEMIA 0/2 (0.00%)   FEBRILE NEUTROPENIA 0/2 (0.00%)   LYMPHADENOPATHY 0/2 (0.00%)   NEUTROPENIA 0/2 (0.00%)   PANCYTOPENIA 0/2 (0.00%)   THROMBOCYTOPENIA 0/2 (0.00%)   ATRIAL FIBRILLATION 0/2 (0.00%)   CARDIAC TAMPONADE 0/2 (0.00%)   PERICARDIAL EFFUSION 0/2 (0.00%)   TACHYCARDIA 0/2 (0.00%)   ABDOMINAL PAIN 0/2 (0.00%)   ABDOMINAL PAIN UPPER 0/2 (0.00%) Adverse Events 2:   Total: 0/1 (0.00%)   ANAEMIA 0/1 (0.00%)   FEBRILE NEUTROPENIA 0/1 (0.00%)   LYMPHADENOPATHY 0/1 (0.00%)   NEUTROPENIA 0/1 (0.00%)   PANCYTOPENIA 0/1 (0.00%)   THROMBOCYTOPENIA 0/1 (0.00%)   ATRIAL FIBRILLATION 0/1 (0.00%)   CARDIAC TAMPONADE 0/1 (0.00%)   PERICARDIAL EFFUSION 0/1 (0.00%)   TACHYCARDIA 0/1 (0.00%)   ABDOMINAL PAIN 0/1 (0.00%)   ABDOMINAL PAIN UPPER 0/1 (0.00%)